Fig. 4.
Survival curves.
(A-C) OS of all MDS patients according to expression of CD7 or CD15 or both. AL-MDS patients were excluded from the analyses. (D) OS of the high-risk MDS patients according to CD7 expression. (E) OS of MDS patients classified as INT-1 by IPSS according to CD7 expression.